Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iamgold Corporation Ordinary Shares (IAG) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance

Iamgold Corporation Ordinary SharesTrade
Ionis Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Iamgold Corporation Ordinary Shares vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Iamgold Corporation Ordinary Shares trades at $17.22 (market cap $10.39B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: Iamgold Corporation Ordinary Shares is the larger of the two by market cap, and Iamgold Corporation Ordinary Shares is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iamgold Corporation Ordinary Shares for 6 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.

IAGIONS
Market Cap
$10.39B$7.04B
Volume
2,784,2902,977,440
Sector
Basic MaterialsHealth
52-Week High
$24.57$86.50
52-Week Low
$10.96$42.38
Typical Hold Time
6 Days0 Days
Enterprise Value
$10.43B$6.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Iamgold Corporation Ordinary Shares

IAG trades at $18.27, down 1.62% today, with technical indicators showing a neutral bias. The company demonstrates strong fundamentals with a P/E of 9.23, net income margin of 31.4%, and ROE of 29.53%. Recent earnings show mixed results with two beats and one miss in the last three quarters. Analyst consensus is moderately bullish with a $22.00 price target, representing 20% upside potential from current levels.

IAG presents a compelling value opportunity with attractive valuation metrics and strong profitability. Key catalysts include Q3 2026 earnings release in November and operational optimization initiatives. Risks include commodity price volatility, execution challenges at mining operations, and potential cost pressures from rising fuel prices that could impact profitability.

Ionis Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IAG

No sentiment data available yet.

IONS
100% Buy0% Sell
Avg holding period · 0 Days

About Iamgold Corporation Ordinary Shares

IAMGOLD is a gold mining company with operations in Canada. It also explores and develops gold properties.

Read more on IAG →

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →